ProfileGDS4718 / 1553918_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 52% 50% 55% 52% 53% 48% 55% 57% 56% 50% 54% 50% 50% 50% 48% 51% 51% 49% 50% 58% 55% 53% 53% 51% 47% 56% 56% 53% 47% 47% 48% 57% 51% 49% 50% 46% 56% 50% 46% 53% 46% 51% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7769854
GSM549102patient 115, normal, homogenized [OPG study]5.6634552
GSM549104patient 119, normal, homogenized [OPG study]5.5203750
GSM549108patient 138, normal, homogenized [OPG study]5.8257855
GSM549119patient 077, normal, homogenized [OPG study]5.6184752
GSM549133patient 032, cancer, homogenized [OPG study]5.6353753
GSM549139patient 042, cancer, homogenized [OPG study]5.3748548
GSM549099patient 107, normal, homogenized [OPG study]5.784455
GSM549109patient 139, normal, homogenized [OPG study]5.9693857
GSM549110patient 046, normal, homogenized [OPG study]5.8414556
GSM549114patient 063, normal, homogenized [OPG study]5.4650650
GSM549122patient 082, normal, homogenized [OPG study]5.7427154
GSM549134patient 033, cancer, homogenized [OPG study]5.4715650
GSM549136patient 036, cancer, homogenized [OPG study]5.4773350
GSM549140patient 044, cancer, homogenized [OPG study]5.4680950
GSM549111patient 047, normal, homogenized [OPG study]5.3752648
GSM549113patient 057, normal, homogenized [OPG study]5.529751
GSM549132patient 031, cancer, homogenized [OPG study]5.5726751
GSM549137patient 038, cancer, homogenized [OPG study]5.4452449
GSM549142patient 047, cancer, homogenized [OPG study]5.6618750
GSM549100patient 110, normal, homogenized [OPG study]6.0125758
GSM549107patient 135, normal, homogenized [OPG study]5.8124155
GSM549115patient 068, normal, homogenized [OPG study]5.6278353
GSM549116patient 072, normal, homogenized [OPG study]5.6904753
GSM549120patient 078, normal, homogenized [OPG study]5.5784451
GSM549131patient 030, cancer, homogenized [OPG study]5.3082547
GSM549118patient 074, normal, homogenized [OPG study]5.8472656
GSM549129patient 027, cancer, homogenized [OPG study]5.8859956
GSM549123patient 088, normal, homogenized [OPG study]5.6902553
GSM549124patient 006, cancer, homogenized [OPG study]5.3581947
GSM549126patient 015, cancer, homogenized [OPG study]5.3092147
GSM549128patient 025, cancer, homogenized [OPG study]5.4046648
GSM549103patient 117, normal, homogenized [OPG study]5.9446557
GSM549117patient 073, normal, homogenized [OPG study]5.499651
GSM549138patient 041, cancer, homogenized [OPG study]5.4225949
GSM549141patient 045, cancer, homogenized [OPG study]5.5072450
GSM549130patient 028, cancer, homogenized [OPG study]5.2888846
GSM549101patient 111, normal, homogenized [OPG study]5.8798156
GSM549105patient 128, normal, homogenized [OPG study]5.5105350
GSM549106patient 134, normal, homogenized [OPG study]5.2685146
GSM549112patient 048, normal, homogenized [OPG study]5.6568253
GSM549125patient 011, cancer, homogenized [OPG study]5.2902446
GSM549127patient 024, cancer, homogenized [OPG study]5.5653951
GSM549135patient 035, cancer, homogenized [OPG study]5.7772355